about
Sucralose Non-Carcinogenicity: A Review of the Scientific and Regulatory Rationale.Mechanistic considerations in cancer risk assessment.Xenobiotic-induced hepatocyte proliferation associated with constitutive active/androstane receptor (CAR) or peroxisome proliferator-activated receptor α (PPARα) is enhanced by pregnane X receptor (PXR) activation in mice.Controversial cytogenetic observations in mammalian somatic cells exposed to extremely low frequency electromagnetic radiation: a review and future research recommendations.Chemicals causing mammary gland tumors in animals signal new directions for epidemiology, chemicals testing, and risk assessment for breast cancer prevention.Health effects associated with measured levels of contaminants in the Arctic.Oxidative stress in the carcinogenicity of chemical carcinogens.Safety assessment of pharmaceuticals: examples of inadequate assessments and a mechanistic approach to assuring adequate assessment.Mechanism of 1,3-dichloropropene-induced rat liver carcinogenesis.Thresholds for the effects of 2-acetylaminofluorene in rat liver.Scientific Opinion on the re-evaluation of butylated hydroxyanisole - BHA (E 320) as a food additiveActivation of nuclear receptor CAR by an environmental pollutant perfluorooctanoic acid.Mechanistic basis for nonlinearities and thresholds in rat liver carcinogenesis by the DNA-reactive carcinogens 2-acetylaminofluorene and diethylnitrosamine.Mode of action in relevance of rodent liver tumors to human cancer risk.
P2860
Q30831612-5FBB47DE-E136-448E-826D-4F394E7340B4Q34154150-D26DC0C4-CBC3-46DA-91B7-F442449C55A5Q34692352-2ADD175C-8C7C-42F8-8B84-4663FFD95302Q36123852-F71A9A8B-EF27-413C-9772-CB0E9575DF8BQ36822187-03B43B63-5F2B-41C0-A14E-9E576EA0072AQ37504193-2C8EFD0B-9007-40FA-BC7A-C24098C4A93BQ38160746-867BC54E-56C9-42B3-9F8D-A7C8540717E7Q41376216-A04B8159-FEE6-4760-8720-67CF06267F73Q42703740-CFA84177-E66D-42C9-A4BA-885A6F9AA4F5Q45123174-3E4B3DCD-D8D5-461C-A73B-1DF8463EFCDAQ47150650-8D7F9EBE-770D-4D71-9643-2ECB72CCE17FQ48233954-C9562333-DF7A-45FC-92BB-746C66E70910Q52077247-9D034206-7525-4B37-BB7E-E384B2799C19Q53265627-9CE590F8-E5EE-4D8E-BC9F-94FDB7999859
P2860
description
1996 nî lūn-bûn
@nan
1996 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Epigenetic carcinogens: evaluation and risk assessment.
@ast
Epigenetic carcinogens: evaluation and risk assessment.
@en
Epigenetic carcinogens: evaluation and risk assessment.
@nl
type
label
Epigenetic carcinogens: evaluation and risk assessment.
@ast
Epigenetic carcinogens: evaluation and risk assessment.
@en
Epigenetic carcinogens: evaluation and risk assessment.
@nl
prefLabel
Epigenetic carcinogens: evaluation and risk assessment.
@ast
Epigenetic carcinogens: evaluation and risk assessment.
@en
Epigenetic carcinogens: evaluation and risk assessment.
@nl
P1476
Epigenetic carcinogens: evaluation and risk assessment.
@en
P2093
Williams GM
P304
P356
10.1016/S0940-2993(96)80041-8
P577
1996-02-01T00:00:00Z